Fundraising FoxPropel Bio Partners — Full Portfolio
5 tracked investments · listed companies and verified rows first
Persephone develops a synbiotic supplement for infants that combines probiotics (keystone Bifidobacterium strains) with prebiotics found in human breast milk to replenish gut bacteria linked to digestion, immunity, and development.
BiotechConsumerDigital HealthFemTechHealthtechSan Diego, US
Stephen Van Dien(CTO)inStephanie Culler(CEO)in
Co-investorsFirst Bight VenturesBioBritFifty YearsHemi Ventures, LlcOcampo CapitalPioneer+13 more
Inherent is an AI research lab, incorporated as a Public Benefit Corporation, developing general-purpose inventive AI systems and "AI Scientist" agents intended to accelerate research and power autonomous labs.
AI & Machine LearningDeep TechEnterprise Software
Co-investorsIndex VenturesRadical VenturesEx/AnteMacroscopic VenturesMetaplanetMythos Ventures Management, Llc
Inherent develops general-purpose AI agents designed to augment scientific research and discovery across disciplines.
AI & Machine LearningDeep Tech
Louis Kirsch(Founder)inTantum Collins(Founder)inEdward Hughes(Founder)Kaloyan Aleksiev(Founder)
Co-investorsMythos Ventures Management, LlcEx/AnteIndex VenturesMacroscopic VenturesMetaplanetRadical Ventures
Inherent Biosciences develops clinical diagnostic solutions using epigenetics and AI to address complex healthcare concerns.
AI & Machine LearningBiotechDigital HealthSalt Lake City, US
Andy Olson(Founder)inKristin Brogaard, PhD(Founder)in
Co-investorsMedMountain VenturesPortfoliaUtah Innovation FundAlliance of Angels
LeonaBio develops novel therapeutics for treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
BiotechMedical Devices
Mark Litton(President and CEO)in
Co-investorsNew Enterprise Associates (NEA)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.